Home > Healthcare & Medical Devices > Bariatric Surgery Devices Market
Bariatric Surgery Devices Market size exceeded USD 1.5 billion in 2020 and is anticipated to grow at over 4.8% CAGR between 2021 and 2027. The growing obese population base, increasing number of obesity-related diseases and lifestyle-related disorders are accelerating the market demand.
Get more details on this report - Request Free Sample PDF
Furthermore, the COVID-19 pandemic is noted to have negatively impacted the global market. Owing to the spread of COVID-19 infection, medical device industry witnessed a noteworthy slump in the sale of bariatric surgery devices especially during the initial months of the pandemic. To contain the spread of the virus, public authorities across the globe imposed various restrictions on the movement of goods and people. Additionally, during the pandemic, all the elective surgeries were postponed or suspended to enable maximum hospital capacity utilization for COVID-19 patients.
Rising rate of morbid obesity density across the globe is stimulating the industry demand. Moreover, the rate of childhood obesity is also noted to increase at an alarming rate. Being overweight from childhood puts children at greater risk than an average adult. In addition, children are exhibiting an earlier onset of chronic conditions like high cholesterol, hypertension and diabetes.
Report Coverage | Details |
---|---|
Base Year: | 2020 |
Market Size in 2020: | 1,516.4 Million (USD) |
Forecast Period: | 2021 to 2027 |
Forecast Period 2021 to 2027 CAGR: | 4.8% |
2027 Value Projection: | 2,149.9 Million (USD) |
Historical Data for: | 2016 to 2020 |
No. of Pages: | 180 |
Tables, Charts & Figures: | 176 |
Segments covered: | Product, Procedure and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Get more details on this report - Request Free Sample PDF
Side effects associated with bariatric surgery such as blood clots, infection, bleeding, constipation, gall stones, among others are prominent factors discouraging patients from opting for surgical procedures for weight management. Furthermore, post-operative risks are very commonly observed in patients including risks such as acid reflux, protein or calorie malnutrition, gallstones, constipation, obstruction of the stomach, etc. Further, several studies also report the increased mental health risks. It is estimated that over 20% patients seeking and undergoing bariatric surgery are diagnosed with behavioural health complications such as anxiety, binge-eating disorder, depression, among others.
Get more details on this report - Request Free Sample PDF
The minimally invasive surgical devices segment dominated more than 90% of the market share in 2020. The high prevalence of obesity-related disorders such as cardiovascular ailment among the population is poised to upsurge the industry growth. For instance, as per the American Heart Association 2021 report, around 217.1 per 100,000 age-adjusted deaths are attributable to cardiovascular disease. Globally, heart-related diseases are one of the leading causes of fatalities. This is expected to spike the acceptance of surgical procedures that in turn are slated to aid the market expansion of bariatric surgery devices. Further, the widespread usage of minimally invasive surgical methods over traditional surgical methods are also slated to augment the segment growth.
Sleeve gastrectomy was valued at USD 682 million in 2020. Increasing adoption of sleeve gastrectomy from surgeons as well as patients coupled with the introduction of technologically advanced products from the manufacturers are some of the prime factors driving the growth.
Get more details on this report - Request Free Sample PDF
North America bariatric surgery devices market accounted for 35% of revenue share in 2020 led by the increasing proportion of obese population base in the region. For instance, in 2020, according to Trust for America’s Health (TFAH), the adult U.S. population obesity rate stands around 42% and the obesity rate is increasing every year which has led to rising in the prevalence of chronic diseases in adults. Obesity can cause severe health-related disorders and is associated with a considerable increase in mortality and morbidity. The region also represents a relatively higher acceptance trends for surgical procedures for weight management, thereby augmenting the industry progression. Furthermore, rising awareness regarding obesity management and the presence of major medical device companies in the region are predicted to escalate the industry value.
Prominent players operating in the market include Apollo Endosurgery, B. Braun Melsungen AG, CONMED Corporation, Ethicon Inc. (Johnson & Johnson), Integra Life Sciences Holding Corporation, Intuitive Surgical, Medtronic, Olympus Corporation, Reshape Lifesciences, W. L. Gore & Associates, Inc. Acquisition, partnerships and collaboration are the most commonly adopted business strategies to sustain market position in bariatric surgery devices.
Market, By Product
Market, By Procedure
The above information is provided for the following regions and countries: